All material on this website and blog is provided for informational purposes only, as of the date hereof, and is subject to change without notice. This material may not be suitable for all investors and is not intended to be an offer, or the solicitation of any offer, to buy or sell any securities. Any investors or other persons who read this site agree to do their own research and make their own investment decisions.
Welcome
Raman Minhas works with entrepreneurial medtech companies, providing support with partnering, financing and exit strategy (through ATPBio). He also invests in medtech stocks using a value-based approach.
-
Recent Posts
- Millionaire Teacher: Index investing for medtech specialists
- Macro insights for specialist investors
- Corporate VCs v VC firms: Are your investors aligned?
- What Every Medtech Entrepreneur Should Know About VCs
- When Neopolitan Beats Vanilla: What Specialist Medtech Investors can Learn from Generalists
- 8 Insights from Medtech Entrepreneurs at BioTrinity, UK
- What’s the Hidden Value in TEVA’s Stock?
- 6 Lessons for Medtech Entrepreneurs from Covidien’s Recent Acquisitions
- Medtech Value Investor’s Magic Number
- Improving Investor Returns: 3 Benefits of Watchlists
Connect
Search
Categories
Archives